Cargando…
D-Arg(0)-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B(2) Receptor Agonist Metabolically Activated by Carboxypeptidases
We previously reported hypotensive and vasodilator effects from C-terminally extended bradykinin (BK) sequences that behave as B(2) receptor (B(2)R) agonists activated by vascular or plasma peptidases. D-Arg(0)-BK-Arg-Arg (r-BK-RR) is a novel prodrug peptide hypothetically activated by two catalytic...
Autores principales: | Bachelard, Hélène, Charest-Morin, Xavier, Marceau, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880945/ https://www.ncbi.nlm.nih.gov/pubmed/29636689 http://dx.doi.org/10.3389/fphar.2018.00273 |
Ejemplares similares
-
In Vivo Effects of Bradykinin B(2) Receptor Agonists with Varying Susceptibility to Peptidases
por: Jean, Mélissa, et al.
Publicado: (2016) -
In Vitro Modeling of Bradykinin-Mediated Angioedema States
por: Marceau, François, et al.
Publicado: (2020) -
Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase–activated B(2) receptor agonists
por: Charest-Morin, Xavier, et al.
Publicado: (2014) -
Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B(2) receptor: application to cytofluorometry and imaging
por: Gera, Lajos, et al.
Publicado: (2016) -
Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B(2) receptor and peptidase resistance in rats
por: Charest-Morin, Xavier, et al.
Publicado: (2017)